From Topology to Treatments
Congruence Therapeutics is a drug discovery company that is uniquely harnessing the power of innovative fields such as protein dynamics, biophysics, machine learning and computational chemistry. Our ground-breaking discovery engine, Revenir™, sees proteins in ways others have been unable to see - in their full dynamic state.
We’re building a world-class team of drug hunters to efficiently design small molecules for diseases with high unmet medical need.
Drug hunters apply here
Congruence closes Series A funding round
The US$50M Series A financing was led by Amplitude Ventures and Fonds de solidarité FTQ, with participation from Lumira Ventures, Investissement Quebec, OrbiMed Advisors, Driehaus and others.
Need to reach us?
If you are interested in a Chemistry position and want to learn more, contact Lee Fader Ph.D., Vice President Chemistry.
Need to reach us?
If you are interested in a Chemistry position and want to learn more, contact Lee Fader Ph.D., Vice President Chemistry.